OSMT - Osmotica Pharmaceuticals EPS beats by $0.08 misses on revenue May, 13 2021 04:30 PM Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals (OSMT): Q1 GAAP EPS of -$0.15 beats by $0.08.Revenue of $23.9M (-50.9% Y/Y) misses by $6.75M.Press Release For further details see: Osmotica Pharmaceuticals EPS beats by $0.08, misses on revenue